A treatment for patients with the most common form of leukaemia has been fast tracked by NICE because of strong …
The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

